A case of amiodarone-induced hypothyroidism in a mild to moderate iodine deficiency area

Roberto Vita, Salvatore Benvenga

Abstract


Thyroid dysfunction associated to amiodarone treatment depends on iodine intake, as thyrotoxicosis occurs more frequently in iodine deficiency areas, whereas hypothyroidism in iodine sufficient areas. We present here a case of severe overt hypothyroidism induced by prolonged treatment with amiodarone for atrial fibrillation in a man living in a low iodine intake area. The case was managed with levothyroxine (LT4) replacement and amiodarone withdrawal. Euthyroidism was restored after two months, and atrial fibrillation has not relapsed to date.

Keywords


amiodarone; hypothyroidism; iodine

Full Text:

PDF

References


Singh B.N. (2008) Amiodarone as paradigm for developing new drugs for atrial fibrillation. J Cardiovas Pharmacol, 52 (4), 300-305.

Basaria, S., Cooper, D.S. (2005) Amiodarone and the thyroid. Am J Med, 118 (7), 706-714.

Narayana, S.K., Woods, D.R., Boos, C.J. (2011) Management of amiodarone-related thyroid problems. TherAdvEndocrinolMetab, 2 (3), 115-126.

Vassallo, P., Trohman, R.G. (2007) Prescribing amiodarone: an evidence-based review of clinical indications. JAMA, 298 (11), 1312-1322.

Siniakowicz, R.M., Narula, D., Suster, B., Steinberg, J.S. (2001) Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J CardiovascElectrophysiol, 12 (4), 431-436.

Figge, J., Dluhy, R.G. (1990) Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism. Ann In Med, 113 (7), 553-555.

Chiovato, L., Martino, E., Tonacchera, M., Santini, F., Lapi, P., Mammoli, C. et al (1994) Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology, 134 (5), 2277-2282.

Trip, M.D., Wiersinga, W., Plomp, T.A. (1991) Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med, 91 (5), 507-511.

Martino, E., Safran, M., Aghini-Lombardi, F., Rajatanavin, R., Lenziardi, M., Fay, M. et al (1984) Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Int Med, 101 (1), 28-34.

Batcher, E.L., Tang, X.C., Singh, B.N., Singh, S.N., Reda, D.J., Hershman, J.M. et al (2007) Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. Am J Med, 120 (10), 880-885.

Trifanescu, R., Fica, S., Barbu, C., Vartej, I., Ursu, H., Bunghez, R., et al (2004) Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency. Rom J Int Med, 42 (3), 595-605.

Loh, K. (2000) Amiodarone-induced thyroid disorders: a clinical review Postgraduate Medical Journal, 76, 133-140

Martino, E., Aghini-Lombardi, F., Mariotti, S., Bartalena, L., Lenziardi, M., Ceccarelli, C. et al.(1987) Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. ClinEndocrinol (Oxf), 26 (2), 227-237.

Martino, E., Bartalena, L., Mariotti S., Aghini-Lombardi, F., Ceccarelli, C., Lippi F et al. (1998) Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. Acta Endocrinol, 119, 167-173.

Bogazzi, F., Tomisti, L., Bartalena, L., Aghini-Lombardi, F., Martino, E. (2012) Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest, 35, 340-348.

Pazin-Filho, A., de Jesus, A.M., Magalhaes, P.K., Melato, L.H., Campos, D., Maciel, B.C. et al (2009) How frequently should a patient taking amiodarone be screened for thyroid dysfunction? Braz J MedBiol Res, 42 (8), 744-749.

Bogazzi, F., Bartalena, L., Tomisti, L., Dell'Unto, E., Cosci, C., Sardella, C. et al (2008). Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy. J Endocrinol Invest 31:515-519.




DOI: https://doi.org/10.6092/1828-6550/APMB.105.2.2017.A6

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Roberto Vita, Salvatore Benvenga

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.